Human Respiratory Epithelial Tissue Models for Opioid-Reversal Nasal Spray Perme
Type: Forecast
Overview
Description
This contract will provide specialized human-derived nasal and respiratory epithelial tissue models and associated culture media required for the FDA-funded project "In Vitro Characterization to Support Development and Approval of Generic Drug Products for Opioid Overdose Reversal" under opioids research awards. The tissues will be used to test permeation of naloxone and nalmefene nasal spray products across physiologically relevant epithelial barriers, generating biorelevant in vitro data to evaluate formulation-dependent drug absorption and support development of alternative in vitro approaches for non-Q1/Q2 generic opioid-overdose reversal products. The purchase is specifically anticipated in the awarded proposal, which allocates project funds for batch orders of 3D human-derived respiratory epithelial tissue models needed for the permeation studies.
Est. Value
Min: $25,000
Max: $250,000
Max: $250,000
Est. Award Date
27-Jan
Future Opp
Source Est. Solicitation Date
26-Nov
Set Aside
To be determined
Place of Performance
USA
Forecast Source
Department of Health and Human Services
Center for Drug Evaluation and Research is forecasted to issue a procurement for Human Respiratory Epithelial Tissue Models for Opioid-Reversal Nasal Spray Perme around 27-Jan worth up to $250,000.
Agency
Source Level 1 Agency
Department of Health and Human Services
Source Level 2 Agency
FDA
Source Level 3 Agency
CDER
Contacts
Potential Bidders and Partners
Similar Active Opportunities
Additional Detail
Date Published
11/6/26
Date Modified
11/7/26
Additional Notes
Program Office: 75F401; Contracting Office: 75F402